HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samir Hanash Selected Research

Sphingomyelins

1/2020Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samir Hanash Research Topics

Disease

68Neoplasms (Cancer)
11/2023 - 06/2002
14Breast Neoplasms (Breast Cancer)
02/2023 - 10/2002
9Lung Neoplasms (Lung Cancer)
01/2023 - 12/2002
8Pancreatic Neoplasms (Pancreatic Cancer)
08/2023 - 11/2004
8Adenocarcinoma of Lung
01/2023 - 08/2002
6Inflammation (Inflammations)
01/2018 - 06/2003
5Neoplasm Metastasis (Metastasis)
11/2023 - 01/2013
5Triple Negative Breast Neoplasms
01/2022 - 08/2015
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 01/2010
4Prostatic Neoplasms (Prostate Cancer)
11/2023 - 11/2003
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2016 - 11/2013
3Leukemia
08/2022 - 01/2016
3Carcinoma (Carcinomatosis)
04/2007 - 03/2005
2Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 02/2021
2Carcinogenesis
05/2021 - 01/2018
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2016
2Bronchiolitis Obliterans Syndrome
01/2020 - 08/2017
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020 - 01/2016
2Adenocarcinoma
01/2019 - 11/2004
2Cardiovascular Diseases (Cardiovascular Disease)
04/2009 - 02/2009
2Endometrioid Carcinoma
04/2007 - 03/2005
2Liver Diseases (Liver Disease)
11/2006 - 09/2004
2Colorectal Neoplasms (Colorectal Cancer)
07/2005 - 11/2002
1Peritoneal Neoplasms
11/2023
1Stomach Neoplasms (Stomach Cancer)
11/2023
1Genomic Instability
11/2023
1Bites and Stings (Sting)
11/2023
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
08/2022
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2021
1Rectal Neoplasms (Rectal Cancer)
07/2021
1Noninfiltrating Intraductal Carcinoma (DCIS)
05/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
11/2023 - 06/2002
26Biomarkers (Surrogate Marker)IBA
11/2023 - 10/2002
9ProteomeIBA
01/2019 - 08/2002
8AntigensIBA
05/2021 - 01/2004
7OligonucleotidesIBA
03/2005 - 11/2002
6DNA (Deoxyribonucleic Acid)IBA
08/2022 - 05/2003
5Messenger RNA (mRNA)IBA
01/2023 - 12/2004
5Fatty Acids (Saturated Fatty Acids)IBA
06/2022 - 04/2006
5Neoplasm Antigens (Tumor Antigens)IBA
05/2021 - 11/2003
4EnzymesIBA
01/2023 - 03/2005
4RNA (Ribonucleic Acid)IBA
08/2022 - 01/2005
4AutoantibodiesIBA
05/2021 - 01/2004
3PolyaminesIBA
01/2023 - 01/2020
3LipidsIBA
06/2022 - 01/2020
3Blood Proteins (Serum Proteins)IBA
07/2021 - 05/2012
3Interleukin-6 (Interleukin 6)IBA
01/2018 - 06/2003
3Surface-Active Agents (Surfactants)IBA
11/2015 - 10/2013
3IgA receptor (protein B)IBA
11/2015 - 10/2013
3beta CateninIBA
04/2007 - 06/2002
2CeramidesIBA
08/2023 - 01/2020
2Docetaxel (Taxotere)FDA Link
02/2023 - 01/2023
2Trastuzumab (Herceptin)FDA Link
02/2023 - 01/2023
2plerixaforFDA Link
02/2023 - 01/2023
2Therapeutic UsesIBA
02/2023 - 01/2023
2Tryptophan (L-Tryptophan)FDA Link
01/2023 - 05/2022
2kynureninaseIBA
01/2023 - 05/2022
2KynurenineIBA
01/2023 - 05/2022
2UbiquitinIBA
08/2022 - 01/2007
2Protein Isoforms (Isoforms)IBA
10/2021 - 09/2002
2Immunoglobulin G (IgG)IBA
05/2021 - 06/2013
2Estrogen ReceptorsIBA
01/2020 - 08/2015
2N',N''-diacetylspermineIBA
01/2020 - 11/2015
2Indicators and Reagents (Reagents)IBA
01/2019 - 01/2018
2Polysaccharides (Glycans)IBA
04/2016 - 06/2011
2Long Noncoding RNAIBA
02/2016 - 02/2016
2Cadherins (E-Cadherin)IBA
01/2016 - 11/2002
2Immunoglobulins (Immunoglobulin)IBA
03/2013 - 11/2003
2Membrane Proteins (Integral Membrane Proteins)IBA
05/2012 - 08/2009
2Tumor Biomarkers (Tumor Markers)IBA
09/2007 - 01/2004
2CytokinesIBA
01/2003 - 12/2002
1Galectin 3 (LGALS3)IBA
11/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2023
1Androgen Receptors (Androgen Receptor)IBA
11/2023
1Galactosylceramides (Galactocerebrosides)IBA
08/2023
1Sulfoglycosphingolipids (Sulfatides)IBA
08/2023
1Kelch-Like ECH-Associated Protein 1IBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1Oncogene Proteins (Oncogene Protein)IBA
01/2023
1Small Interfering RNA (siRNA)IBA
08/2022
1Thyroid Nuclear Factor 1IBA
01/2022
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2022
1B7-H1 AntigenIBA
01/2022
1Apoptosis Regulatory ProteinsIBA
01/2022
1Proline (L-Proline)FDA Link
10/2021
1Alanine (L-Alanine)FDA Link
10/2021
1Cathepsin BIBA
07/2021
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
07/2021
1Insulin-Like Growth Factor Binding Protein 4IBA
07/2021
1EpitopesIBA
05/2021
1Ribosomal DNA (rDNA)IBA
11/2020
1Progesterone Receptors (Progesterone Receptor)IBA
01/2020
1amsonic acid (DAS)IBA
01/2020
1CholesterolIBA
01/2020

Therapy/Procedure

18Therapeutics
11/2023 - 08/2002
4Drug Therapy (Chemotherapy)
01/2022 - 01/2007
4Cell Transplantation
01/2019 - 10/2015
3Immunotherapy
01/2019 - 01/2007
1Neoadjuvant Therapy
07/2021